Maryland’s Immunomic Therapeutics Exceeds Fundraising Goal, Envisions Future IPO

William Hearl - CEO, Chairman of the Board, and Founder of Immunic Therapeutics
Published on :

Maryland’s Immunomic Therapeutics Exceeds Fundraising Goal, Envisions Future IPO Immunomic Therapeutics Incorporated (ITI), located in Rockville, Maryland recently announced it had closed on $61.3M in financing, exceeding its initial fundraising [….]